Jodi Regts | Senior Director, Corporate Affairs |
Simon Pimstone | President and CEO |
Ian Mortimer | CFO and COO |
Maury Raycroft | Jefferies |
Philomena Kamya | Stifel |
Good day, ladies and gentlemen, and welcome to the Xenon Pharmaceuticals' Fiscal Year 2017 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to Ms.